Atherogenic Index of Plasma and the Risk of In-Stent Restenosis in Patients with Acute Coronary Syndrome beyond the Traditional Risk Factors-Reference-Cited by-同舟云学术

Atherogenic Index of Plasma and the Risk of In-Stent Restenosis in Patients with Acute Coronary Syndrome beyond the Traditional Risk Factors

Published:2021 Issue: Volume: Page:
ISSN:1340-3478
Container-title:Journal of Atherosclerosis and Thrombosis
language:en
Short-container-title:JAT

Author:

Zhu Yong¹,Chen Maolin²,Liu Kesen¹,Gao Ang¹,Kong Xiangyun³,Liu Yan¹,Han Hongya¹,Li Hong¹,Zhu Huagang¹,Zhang Jianwei¹,Zhao Yingxin¹

Affiliation:

1. Department of Cardiology, Beijing AnZhen Hospital, Capital Medical University

2. Department of Emergency, Beijing AnZhen Hospital, Capital Medical University

3. Department of Cardiology, Beijing LuHe Hospital, Capital Medical University

Publisher

Japan Atherosclerosis Society

Subject

Biochemistry, medical,Cardiology and Cardiovascular Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/jat/advpub/0/advpub_63136/_pdf

Reference35 articles.

1. 1) Roth GA, Forouzanfar MH, Moran AE, Barber R, Nguyen G, Feigin VL, Naghavi M, Mensah GA, and Murray CJL: Demographic and Epidemiologic Drivers of Global Cardiovascular Mortality. N Engl J Med, 2015; 372: 1333-1341

2. 2) Timmis A, Townsend N, Gale C, Grobbee R, Maniadakis N, Flather M, Wilkins E, Wright L,Vos R, Bax J, Blum M, Pinto F, and Vardas P: European Society of Cardiology: Cardiovascular Disease Statistics 2017. Eur Heart J, 2018; 39: 508-579

3. 3) Xiao C, Dash S, Morgantini C, Hegele RA, and Lewis GF: Pharmacological Targeting of the Atherogenic Dyslipidemia Complex: The Next Frontier in CVD Prevention Beyond Lowering LDL Cholesterol. Diabetes, 2016; 65: 1767-1778

4. 4) Chapman MJ, Ginsberg HN, Amarenco P, Andreotti F, Borén J, Catapano AL, Descamps OS, Fisher E, Kovanen PT, Kuivenhoven JA, Lesnik P, Masana L, Nordestgaard BG, Ray KK, Reiner Z, Taskinen MR, Tokgözoglu L, Tybjærg-Hansen A, and Watts GF: Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management. Eur Heart J, 2011; 32: 1345-1361

5. 5) Castañer O, Pintó X, Subirana I, Amor AJ, Ros E, Hernáez Á, Martínez-González MÁ, Corella D, Salas-Salvadó J, Estruch R, Lapetra J, Gómez-Gracia E, Alonso-Gomez AM, Fiol M, Serra-Majem L, Corbella E, Benaiges D, Sorli JV, Ruiz-Canela M, Babió N, Sierra LT, Ortega E, and Fitó M: Remnant Cholesterol, Not LDL Cholesterol, Is Associated with Incident Cardiovascular Disease. J Am Coll Cardiol, 2020; 76: 2712-2724

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association Between Remnant Cholesterol and Contrast-Induced Nephropathy in Patients Undergoing Coronary Angiography and/or Percutaneous Coronary Intervention;Angiology;2024-01-07

2. Deteriorative Effect of a Combination of Hypertriglyceridemia and Low High-Density Lipoprotein Cholesterolemia on Target Lesion Revascularization after Everolimus-Eluting Stent Implantation;Journal of Atherosclerosis and Thrombosis;2023-12-01

3. Association of atherogenic index of plasma with early neurological deterioration in patients with acute ischemic stroke;Clinical Neurology and Neurosurgery;2023-11

4. Atherogenic Index of Plasma Predicts Obstructive Coronary Artery Disease in Patients with Stable Angina Pectoris;Diagnostics;2023-10-19

5. The predictive value of atherogenic index of plasma for cardiovascular outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention with LDL-C below 1.8mmol/L;Cardiovascular Diabetology;2023-06-26